Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
2(50.0%)
Phase 3
1(25.0%)
N/A
1(25.0%)
4Total
Phase 2(2)
Phase 3(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03552731Unknown

Evaluation of Depression and Anxiety in Chemotherapy Patients

Role: lead

NCT03211910Not ApplicableWithdrawn

Sacral Savers: Study of Prevention and Enhanced Healing of Sacral and Trochenteric Ulcers

Role: lead

NCT02625454Phase 2Unknown

Reduction of Intrapartum Fever With Intravenous Acetaminophen

Role: lead

NCT02915289Phase 3Completed

Chlorhexidine Gluconate vs Povidone-Iodine Vaginal Cleansing Solution Prior to Cesarean Delivery

Role: lead

NCT03545516Phase 2Unknown

Wound Infiltration as Part of an Opioid Free Pain Management Pathway Following Cesarean Delivery

Role: lead

All 5 trials loaded